Entity
  • BeAble Capital SGEIC SA

    Created in 2015
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    703 2,259
  • Entity types

  • Location

    Calle de Génova, 11, 1º, 28004 Madrid, Spain

    Madrid

    Spain

  • Employees

    Scale: 2-10

    Estimated: 24

  • Engaged corporates

    11
    1 8
  • Added in Motherbase

    1 year, 6 months ago
Description
  • Value proposition

    Science Equity for Tomorrow's Industry.

    Independent Venture Capital firm specialized in Indutrial High Technology transfer and Seed and Early stages.

    Investment on Seed and Early Stage in Industrial High Technologies with the goal to transfer to the society the technologies coming from academic and research institutions, providing support for translating breakthrough discoveries into products thorught start-ups internationally competitive.

    Focus on Deep Science and Technology Transfer - The process of transforming the results of research and development into marketable products and services through the creation of start-up businesses or spin-out companies. We build close ties with universities, research centers, technology transfer offices, industrial companies to access promising projects. The selection process involves the evaluation of scientific research, intellectual property, competitive technologies both from a scientific and marketing perspective.

    Dealing with disruptive technologies with with sustainable competitive advantages based on the company’s IP and know-how and high added value.

    Investment strategy on High Technology (Key Enabling Technologies) - Nanotechnology, Advanced Materials, Photonics, Micro and Nanoelectronic, Industrial Biotechnology and ITC.

    Expertise on the development on the first phases of industrial start-ups: Proof of Concept, Escalation, Pilot Plant or Prototipe, Flag-Ship, Pre-Industrial phases and launching to the market, , where the companies can be financed further by the normal Venture capital / Private equity investor.

    Venture Capital, Seed and Early Stage Capital, Technology Evaluation, Investment, Industrial Technology, Nanotechnology, Photonics, Biotechnology, Microelectronics, Advanced Materials, and Nanoelectronics

Corporate interactions BETA
Corporate TypeTweets Articles
Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Other

26 Feb 2022


Similar entities
Loading...
Loading...
Social network dynamics